| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 02/10/2005 | US20050032194 Protease deficient caulobacter host cells |
| 02/10/2005 | US20050032193 Caldothrix species for use in degradation of organic waste; bioremediation and composting |
| 02/10/2005 | US20050032192 Products containing quantum of bioparticles and method for production thereof |
| 02/10/2005 | US20050032191 Method for production of S-hydroxynitrile lyase by use of escherichia coli |
| 02/10/2005 | US20050032189 Novel protein derived from agkistrodon saxatilis emelianov and process preparing the same |
| 02/10/2005 | US20050032188 Construction of bacillus licheniformis T1 strain, and fermentation production of crude enzyme extract therefrom |
| 02/10/2005 | US20050032187 Novel peptide-forming enzyme, microbe producing the enzyme and method for producing peptide using them |
| 02/10/2005 | US20050032185 3-phosphoinositide-dependent protein kinase that phosphorylates and activates protein kinase B alpha; drug target for cancer; drug screening for enzyme inhibitors as anticancer agents |
| 02/10/2005 | US20050032181 Using actinomycete as degratory agents in biodegradation of polylactide resins comprised of poly-L-lactic acid or a copolymer of poly-L/D-lactic acid; bioremediation and plastic wastes |
| 02/10/2005 | US20050032179 Nucleotide sequences coding for the ccpA1 gene |
| 02/10/2005 | US20050032178 Process for the fermentative preparation of L-amino acids using strains of the enterobacteriaceae family |
| 02/10/2005 | US20050032176 Modular polyketide synthases with altered activity |
| 02/10/2005 | US20050032172 Expression vector comprising nucleotide sequences coding tumor necrosis factor (FTHMA-) and/or axon guidance receptor (T85) for use in identifying modulators for prevention and/or treatment of cell proliferative or neurological disorders |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032168 17 human secreted proteins |
| 02/10/2005 | US20050032161 Novel xanthine phosphoribosyl transferase |
| 02/10/2005 | US20050032159 Method for low-temperature culture of microorganism |
| 02/10/2005 | US20050032158 Using novel g-protein coupled taste receptor (T1R2) as tools in identifying modulators to use as additives which enhance sweetness of foods consumed by animal and humans |
| 02/10/2005 | US20050032157 Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof |
| 02/10/2005 | US20050032156 Identification and characterization of phosphate transporter genes |
| 02/10/2005 | US20050032155 Expression vector comprising nucleotide sequences coding defective receptor protein for use as model in treatment and prevention of convulsive disorders |
| 02/10/2005 | US20050032125 Constitutively translocating cell line |
| 02/10/2005 | US20050032107 Method of screening anti-mycobacterial molecules |
| 02/10/2005 | US20050032103 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus |
| 02/10/2005 | US20050032085 Novel chromophores/fluorophores and methods for using the same |
| 02/10/2005 | US20050032078 Methods for the detection, analysis and isolation of nascent proteins |
| 02/10/2005 | US20050032059 Genetically modified hydrolase comprising enhanced activity for use in hydrolysis of starch to glucose; textile treatment; preparation of animal feeds |
| 02/10/2005 | US20050032054 Screening for novel bioactivities |
| 02/10/2005 | US20050031649 Bacillus Calmette Guerin (BCG) heat shock protein; treating breast cancer, ovarian cancer, colon cancer, prostate cancer and lung cancer |
| 02/10/2005 | US20050031647 Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof |
| 02/10/2005 | US20050031645 Vaccine compositions |
| 02/10/2005 | US20050031644 Modifying wild strain of enteroinvasive Shigella; cannot spread within infected cells and from infected to uninfected cells of the host; vaccines; deactivation by inserting transposon into gene; mutagenizing; genetically engineered by allelic exchange |
| 02/10/2005 | US20050031601 Composition comprising a lactobacillus pentosus strain and uses thereof |
| 02/10/2005 | US20050029191 Separation medium, its preparation and its use |
| 02/10/2005 | DE10011728B4 Verfahren zur Leistungssteigerung mikrobieller Systeme A method for performance improvement of microbial systems |
| 02/10/2005 | CA2820028A1 Multimeric oxidoreductases |
| 02/10/2005 | CA2534360A1 Methods for expression and purification of immunotoxins |
| 02/10/2005 | CA2534275A1 Pichia methanolica secretory signal |
| 02/10/2005 | CA2533938A1 Multimeric oxidoreductases |
| 02/10/2005 | CA2533936A1 Metabolically engineered bacterial strains having enhanced 2-keto-d-gluconate accumulation |
| 02/10/2005 | CA2533559A1 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof |
| 02/10/2005 | CA2533160A1 Genotoxicity testing |
| 02/09/2005 | EP1505160A2 5'nucleases derived from thermostable DNA polymerase |
| 02/09/2005 | EP1505155A1 Novel carbonyl reductase, gene thereof and use of the same |
| 02/09/2005 | EP1505153A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 02/09/2005 | EP1505152A1 EXPRESSION SYSTEMS FOR STEM LOOP RNA MOLECULE HAVING RNAi EFFECT |
| 02/09/2005 | EP1505149A1 Methylotroph producing mammalian type sugar chain |
| 02/09/2005 | EP1505075A1 Antibody to human insulin-like growth factor |
| 02/09/2005 | EP1505074A1 Histamine receptor h3 ordinary activity mutant and utilization thereof |
| 02/09/2005 | EP1504111A2 Nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues, and methods of making same |
| 02/09/2005 | EP1504107A1 Recombinant fowlpox virus |
| 02/09/2005 | EP1504103A1 Promoters having a modified transcription efficiency and derived from methyltrophic yeast |
| 02/09/2005 | EP1504099A2 Novel nucleic acids and polypeptides |
| 02/09/2005 | EP1504095A2 Site specific listeria integration vectors and methods for using the same |
| 02/09/2005 | EP1504093A2 Rna detection enzymes |
| 02/09/2005 | EP1504091A2 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants |
| 02/09/2005 | EP1504090A2 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors |
| 02/09/2005 | EP1504030A2 Constitutively translocating cell line |
| 02/09/2005 | EP1504027A2 Adipocyte complement related protein zacrp8 |
| 02/09/2005 | EP1504017A2 Mutant chromophores/fluorophores and methods for making and using the same |
| 02/09/2005 | EP1503985A2 Polypeptides and biosynthetic pathways |
| 02/09/2005 | EP1503776A1 Method of enhancing biological activity of plant extracts |
| 02/09/2005 | EP1503715A2 High-quality lipids and methods for producing by enzymatic liberation from biomass |
| 02/09/2005 | EP0843818B1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
| 02/09/2005 | EP0700438B1 Opioid receptors: compositions and methods |
| 02/09/2005 | CN1578839A Modulating urea degradation in wine yeast |
| 02/09/2005 | CN1578837A Regulated nucleic acid expression system |
| 02/09/2005 | CN1578836A Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 02/09/2005 | CN1578834A Genes coding for metabolic pathway proteins |
| 02/09/2005 | CN1578832A Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants |
| 02/09/2005 | CN1578831A Fungal micro-organism having an increased ability to carry out biotechnological process(es) |
| 02/09/2005 | CN1578785A Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 02/09/2005 | CN1578678A Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/09/2005 | CN1576365A 葡萄糖脱氢酶 Glucose dehydrogenase |
| 02/09/2005 | CN1576362A Cordycepin food and cordycepin substrate and preparing process thereof |
| 02/09/2005 | CN1188527C Process for biotransformation of colchicone compound into correspoonding 3-o-glycosyl derivatives |
| 02/09/2005 | CN1188525C Improved i (agrobacterium)-mediated transformation of plants |
| 02/09/2005 | CN1188523C Blue-green alga shuttle plasmid expression vector and method for expressing thymison alpha1 |
| 02/09/2005 | CN1188519C Fusion proteins comprising HIV-1 Tat and /or Nef proteins |
| 02/09/2005 | CN1188515C Solid fermentation process of streptomyces flavus and its production equipment |
| 02/09/2005 | CN1188514C Malate-lactic acid bacteria SD-2a and application |
| 02/09/2005 | CN1188513C Prepn and use of enzyme prepn for use in hemp degluing industrial process |
| 02/09/2005 | CN1188512C Microorganism producing L- lysine and processes for producing L- lysine using same |
| 02/09/2005 | CN1188511C Method for producing yeast powder by using beer waste yeast |
| 02/09/2005 | CN1188510C Solid-phase hair weeds raising method |
| 02/09/2005 | CN1188172C G-CSF conjugates |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | US6852838 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders |
| 02/08/2005 | US6852837 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 02/08/2005 | US6852836 Gene encoding brain-specific membrane protein |
| 02/08/2005 | US6852835 DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses |
| 02/08/2005 | US6852704 Compositions and methods for reverse gene therapy, wherein a gene therapy vector encoding a gene product (e.g. a protein) which is usually only expressed in cells of an abnormal tissue is delivered to a cell of an animal afflicted with a disease |
| 02/08/2005 | US6852528 Human and mouse uroplakin II gene transcriptional regulatory elements |
| 02/08/2005 | US6852523 B.subtilis, wherein one or more genes involved in the biosynthesis of isovaleric acids have been modified such that the strain cannot produce substantial amounts of isovaleric acids; improved food flavors |
| 02/08/2005 | US6852520 DSP-2 dual-specificity phosphatase |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852516 Culturing a coryneform bacterium which has been modified to increase intracellular pyruvate carboxylase activity and L-glutamic acid producing ability in a medium to produce and accumulate L-glutamic acid in culture |
| 02/08/2005 | US6852511 Heat-inducible promoter |
| 02/08/2005 | US6852506 For neurological/vision/kidney/liver diagnosis/therapy; embryogenesis/angiogenesis activators; anticancer/tumor agents; wound healing agents |
| 02/08/2005 | US6852497 Fusion protein |